AIDS2014post
Latest Post

AIDS 2014: Engaging Injection Drug Users in Kenya and Tanzania

Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia this week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA –  During a symposium on harm reduction and people who use drugs on Friday, research from Kenya and Tanzania points to strategies and services to increase the participation […]

More »

Recent Posts

aids2014

AIDS 2014: Pediatric treatment planning, action call at last plenary

Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia this week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA –   Shaffiq Essajee spoke during today’s plenary session about HIV prevention and treatment for children with a strong focus on the treatment side. “While we are seeing 60 […]

More »
aids2014

AIDS 2014: Antiretroviral treatment update kicks off final plenary session

Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia this week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA –  Professor David Cooper kicked off the final opening plenary in Melbourne today with a review on antiretroviral therapy including a review of recommended drug regimens for first […]

More »
aids2014

AIDS 2014: Activists hold die-in to protest high price of Gilead’s hepatitis C drug

Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA -  Activists surprised Gilead corporate executives today with a “die-in” to protest the pricing of Gilead’s hepatitis C drug, Solvaldi (sofosbuvir). As Gregg Alton, Gilead’s Executive Vice-President […]

More »
More Recent Posts »

Live Blog Archive

CODEL Video

Click above for a video on our Congressional study tour to Africa, and click here to read more.

HIV

UNAIDS HIV Gap Report highlights inequity of gains, says inclusion and ambitious acceleration could end epidemic by 2030

Of 35 million people living with HIV, 19 million do not know it. While new infections dropped by 13 percent in last three years, more than […]

Tuberculosis

PaMZ TB drug regimen: Cheaper, simpler, safer and with effectiveness “significantly greater” than standard regimen, researchers say

An analysis of eight-week data from a clinical trial of a tuberculosis treatment regimen shows the promise of curing the disease in a shorter period of […]

Research & Development

Tuberculosis R&D must be U.S. diplomatic priority, say global health leaders

Along with maintaining funding for fighting global tuberculosis, the United States government must better coordinate with the most affected countries on TB research and development, said […]

Policy

The Voice of Public Health Leadership Globally: Marginalized

The following is a guest post by Ron MacInnis, Deputy Director for HIV. By Ron MacInnis WASHINGTON, DC — My visit to Uganda last month – […]